The development offers state-of-the-art facilities for the European headquarters of Illumina, a world leader in Genomic Analysis and Diagnostics.
Long-term flexibility is a key design objective with the potential for open office space to be converted to specialist laboratories in the future. Feilden+Mawson have delivered the 3 storey, 19,500m² project from RIBA Stage 3.